ask="50.00"
ask_size="700"
average_daily_volume="379148"
bid="N/A"
bid_size="N/A"
book_value="6.19"
change="+0.39"
change_from_200_day_moving_average="0.14"
change_from_50_day_moving_average="-1.15"
change_from_52_week_high="-8.62"
change_From_52_week_low="16.71"
change_in_percent="+1.30%"
close="30.30"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.06"
ebitda="-175.77M"
eps_estimate_current_year="-3.83"
eps_estimate_next_quarter="-1.03"
eps_estimate_next_year="-3.92"
ex_dividend_date="N/A"
float_shares="31803000"
high="30.70"
high_52_weeks="38.92"
last_trade_date="2/2/2017"
last_trade_price="30.30"
last_trade_size="12422"
last_trade_time="4:00pm"
low="29.56"
low_52_weeks="13.59"
market_capitalization="1.57B"
moving_average_200_day="30.16"
moving_average_50_day="31.45"
name="Theravance Biopharma
Inc."
notes="N/A"
one_year_target_price="34.71"
open="29.73"
pe_ratio="N/A"
peg_ratio="-0.02"
percent_change_from_200_day_moving_average="+0.46%"
percent_change_from_50_day_moving_average="-3.67%"
percent_change_from_52_week_high="-22.15%"
percent_change_from_52_week_low="+122.96%"
previous_close="29.91"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.83"
price_per_sales="33.16"
revenue="46.85M"
shares_outstanding="51942000"
short_ratio="18.07"
stock_exchange="NGM"
symbol="TBPH"
volume="151670"
weeks_range_52="13.59 - 38.92"
